Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• For patients with HFpEF, medical therapy options now abound Erik Swain
• Benefits of hemodynamic-guided HF management may extend to broader range of patients Katie Kalvaitis
• CRT devices, His bundle pacing, reducing complications focus of new ESC pacing guideline Erik Swain
• CV safety of prostate cancer therapies ‘remains unresolved’: PRONOUNCE Scott Buzby
• Daily walnut consumption lowers total cholesterol, LDL at 2 years Brian Ellis
• Edoxaban ‘plausible alternative to warfarin’ to treat AF after TAVR Scott Buzby
• FDA approves empagliflozin for treatment of HFrEF in patients with or without diabetes
• FDA approves LAA occlusion device for treatment of AF in patients at high risk for stroke
• Flavonoid-rich foods confer BP benefits, partly explained by gut bacteria Erik Swain
• Lancet Women and CVD Commission: Reducing the global burden by 2030 Anjali A. Wagle, MD; Andrew Gagel, MD; Roger S. Blumenthal, MD; Garima Sharma, MD
• Metoprolol safe, reduces lung inflammation in patients with severe COVID-19 Brian Ellis
• Portico TAVR system gains FDA approval for very high-risk patients
• Moderate alcohol consumption associated with reduced CV mortality, events Erin T. Welsh, MA
• ‘Quadpill’ strategy effective, safe, tolerable vs. monotherapy for BP lowering Scott Buzby
• Anti-arrhythmic effects of SGLT2 inhibitors 'may be an alias for improving heart failure' Scott Buzby
• Longer duration diabetes, prediabetes increase heart failure risk Jill Rollet
• ENVISAGE-TAVI AF
• IAMI
• PRESERVED-HF
• PRONOUNCE
• QUARTET
• REDWOOD-HCM
• TARGET-HF-DM
• WAHA